A comprehensive multidisciplinary approach to target the inhibitory kappa B kinase pathway to discover novel therapies in prostate cancer

Project: Research

Project Details

StatusFinished
Effective start/end date1/04/0830/04/14

Funding

  • Cancer Research UK CRUK: £500,000.00
  • Cancer Research UK CRUK: £601,965.00
  • Cancer Research UK CRUK: £525,000.00
  • Cancer Research UK CRUK: £551,250.00
  • Cancer Research UK CRUK: £578,812.00

Research Output

Inhibitory Kappa B kinase α (IKKα) inhibitors that recapitulate their selectivity in cells against isoform-related biomarkers

Anthony, N. G., Baiget, J., Berretta, G., Boyd, M., Breen, D., Edwards, J., Gamble, C., Gray, A. I., Harvey, A. L., Hatziieremia, S., Ho, K. H., Huggan, J. K., Lang, S., Llona-Minguez, S., Luo, J. L., McIntosh, K., Paul, A., Plevin, R. J., Robertson, M. N., Scott, R. & 4 others, Suckling, C. J., Sutcliffe, O. B., Young, L. C. & MacKay, S. P., 24 Jul 2017, In : Journal of Medicinal Chemistry. 60, 16, p. 7043-7066 24 p.

Research output: Contribution to journalArticle

Open Access
File
  • 6 Citations (Scopus)
    135 Downloads (Pure)